ArticleNaunyn-Schmiedeberg's archives of pharmacology2025
Synthesis, characterization, and drug delivery application of carboxymethyl chitosan-CTAB self-assembling.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In this study, self-assembly vesicles based on carboxymethyl chitosan (CMCS) were prepared for insulin delivery. The self-assembly behavior of mixed systems consisting of CMCS and the cetyl trimethyl ammonium bromide (CTAB) was investigated. The resulting CMCS/CTAB vesicles were nearly spherical in shape, with the majority ranging around 100 nm in diameter. The toxicity profile of CMCS/CTAB vesicles was evaluated in vitro via methyl thiazolyl tetrazolium (MTT) assay. The results indicated that the stability of CMCS/CTAB vesicles was enhanced by increasing the degree of substitution (DS) of CMCS or by reducing the molecular weight (MW) of CMCS. Additionally, we observed that vesicle stability improved with decreased temperature. The insulin loading capacity and encapsulation efficiency decreased as the MW increased. Moreover, the loading capacity and encapsulation efficiency increased with the increase of the DS. The release of insulin slowed as the insulin content increased. The increase of MW or DS of CMCS could slow the release of insulin.
Indexed as
Identifiers
40488852What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.